Pharsight Customers
Pharsight® software products and scientific consulting services enable strategic decision-making in clinical drug development. Pharsight solutions integrate complementary drug development disciplines, novel model-based approaches and advanced software technology to address the needs of our pharmaceutical and biotechnology industry customers worldwide.
Pharsight's customer base includes the following leading companies:
Abbott |
Gilead Sciences |
Akzo Nobel |
GlaxoSmithKline |
Alcon |
IMPAX Laboratories |
Allergan |
IPSEN |
Altana |
Jannsen, L.P. |
Amgen |
Johnson & Johnson |
Astellas |
Kowa |
AstraZeneca |
Merck |
Bausch & Lomb |
Merck KGaA |
Baxter |
Millennium |
Bayer |
N.V. Organon |
Biogen Idec |
Novartis |
Biovail Technologies |
NovoNordisk |
Boehringer Ingelheim |
Ono |
Bristol-Myers Squibb |
Pfizer |
Centocor |
Proctor & Gamble |
Cephalon |
Roche |
Chiron |
Sanofi-Aventis |
Chugai |
Schering AG |
Daiichi Sankyo |
Schering-Plough |
Debiopharm |
Sepracor |
deCODE Genetics |
Serono |
DOV Pharmaceuticals |
Servier |
Eisai |
Solvay |
Elan |
Takeda |
Eli Lilly |
Tanabe |
Forest |
Teva |
Galderma |
3M |
Genentech |
Vertex |
Genzyme |
Wyeth |